Mar-05-16
The EFIRM diagnostic system uses an electric field to detect cancer mutations in saliva, offering a less painful and potentially more accurate reading.
Developed by a team from the University of California, the EFRIM (electric field-induced release and measurement) uses an electric field to trigger the release of cancer biomarkers, such as RNA, in a saliva sample. Research has determined that salivary diagnostic tests are “almost 100 percent accurate,” and the new test is the first targeted at identifying cancer. The testing device is also portable, allowing the samples to processed at any location, and the team envisions a time when such diagnostic devices are commercially available for home use.
Add Your Comment